Can we test drugs to delay or prevent the onset of Huntington's disease? New research suggests it's possible
Ionis says its trial of HTTRx, intended to lower huntingtin protein, is fully recruited and plans to extend it
WAVE Life Sciences launches PRECISION clinical trial to suppress the mutant Huntington's disease protein
A potential HD biomarker has been uncovered in a recent clinical study
Deutetrabenazine becomes the first new drug in a decade licensed by the FDA for symptoms of Huntington's disease
Pfizer announces the 'Amaryllis' trial of a PDE-10 inhibitor drug failed to improve symptoms of HD
HDBuzz helps untangle some bold claims about the just-announced results of the PRIDE-HD trial of pridopidine in HD
A new scientific paper & lots of headlines about deutetrabenazine, a twist on treating chorea in Huntington's disease
HDBuzz summarizes the science from an unusually large and energized @HDSA convention in Baltimore